310 results match your criteria: "Leipzig Heart Institute[Affiliation]"
Eur Heart J Acute Cardiovasc Care
December 2024
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Circulation
October 2024
Levine Cardiac Intensive Care Unit, TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (D.A.M.).
Background: Cardiogenic shock remains highly associated with early mortality, with mortality often exceeding 50%. We sought to determine the association between prognostic factors and in-hospital and 30-day mortality in cardiogenic shock.
Methods: We performed a systematic review and meta-analysis of prognostic factors in cardiogenic shock, searching MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials for records up to June 5, 2023.
Eur Heart J Case Rep
October 2024
Electrophysiology Department, Heart Center, University of Leipzig, Strümpellstraße 39, 04289 Leipzig, Germany.
J Card Fail
October 2024
Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA.
Am Heart J
December 2024
Institute of Cardiology, Madre Giuseppina Vannini Hospital, Rome, Italy; Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University, Rome, Italy.
Background: Few data are available on long-term drug therapy and its potential prognostic impact after Takotsubo syndrome (TTS). Aim of the study is to evaluate clinical characteristics and long-term outcome of TTS patients on Renin Angiotensin system inhibitors (RASi).
Methods: TTS patients were enrolled in the international multicenter GEIST (GErman Italian Spanish Takotsubo) registry.
Eur Heart J Cardiovasc Imaging
December 2024
HerzZentrum Hirslanden, Hirslanden Clinic, Zurich, Switzerland.
Front Cardiovasc Med
July 2024
Department of Cardiology, Angiology and Intensive Care Medicine, German Center for Cardiovascular Research (DZHK), University Heart Center Lübeck, Medical Clinic II, University of Lübeck, Lübeck, Germany.
J Am Coll Cardiol
May 2024
University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria. Electronic address:
Background: The prognostic significance of various microvascular injury (MVI) patterns after ST-segment elevation myocardial infarction (STEMI) is not well known.
Objectives: This study sought to investigate the prognostic implications of different MVI patterns in STEMI patients.
Methods: The authors analyzed 1,109 STEMI patients included in 3 prospective studies.
EuroIntervention
May 2024
Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Intensive Care Med
June 2024
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.
Purpose: Cardiogenic shock secondary to acute myocardial infarction (AMI-CS) is associated with substantial short- and long-term morbidity and mortality. However, there are limited data on mental health sequelae that survivors experience following discharge.
Methods: We conducted a retrospective, population-based cohort study in Ontario, Canada of critically ill adult (≥ 18 years) survivors of AMI-CS, admitted to hospital between April 1, 2009 and March 31, 2019.
J Clin Med
March 2024
Department of Internal Medicine/Cardiology and Leipzig Heart Institute, Heart Center Leipzig at University of Leipzig, Strümpellstr. 39, Russenstraße 69a, 04289 Leipzig, Germany.
The proportion of patients with multivessel coronary artery disease in individuals experiencing acute coronary syndrome (ACS) varies based on age and ACS subtype. In patients with ST-segment elevation myocardial infarction (STEMI) without cardiogenic shock, the prognostic benefit of complete revascularization has been demonstrated by several randomized trials and meta-analyses, leading to a strong guideline recommendation. However, similar data are lacking for ACS without ST-segment elevation (NSTE-ACS).
View Article and Find Full Text PDFEur J Heart Fail
April 2024
Department of Cardiology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
JACC Basic Transl Sci
February 2024
Department of Cardiology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
Am Heart J
May 2024
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:
Background: Mortality after ST-segment elevation myocardial infarction (STEMI) is increased in patients with hypertension. The mechanisms underlying this association are uncertain. We sought to investigate whether patients with STEMI and prior hypertension have greater microvascular obstruction (MVO) and infarct size (IS) compared with those without hypertension.
View Article and Find Full Text PDFBackground: Neurological disorders as a risk factor for Takotsubo syndrome (TTS) are not well characterized. The aim of the study was to evaluate TTS-associated neurological phenotypes and outcome.
Methods And Results: Patients with TTS enrolled in the international multicenter GEIST (German Italian Spanish Takotsubo) registry were analyzed.
J Am Heart Assoc
February 2024
Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine) and German Center for Cardiovascular Research, partner site Hamburg/Kiel/Lübeck University Heart Center Lübeck Lübeck Germany.
Background: The role of age in the short- and long-term prognosis of takotsubo syndrome (TTS) is controversial. The aim of the present study was to evaluate age-related differences and prognostic implications among patients with TTS.
Methods And Results: In total, 2492 consecutive patients with TTS enrolled in an international registry were stratified into 4 groups (<45, 45-64, 65-74, and ≥75 years).
Atherosclerosis
February 2024
University of Foggia, Department of Medical and Surgical Sciences, Foggia, Italy.
Background And Aims: Several studies have shown that endothelial dysfunction plays a role in the pathogenesis of Takotsubo syndrome (TTS). Given the potential benefit of statin therapy on endothelial dysfunction, we hypothesized that such treatment could improve outcome. Aim of our study was to evaluate clinical characteristics and outcome of TTS patients treated with statin therapy.
View Article and Find Full Text PDFEur J Heart Fail
February 2024
Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig, Germany.
Aims: Anaemia and iron deficiency (ID) are common comorbidities in cardiovascular patients and are associated with a poor clinical status, as well as a worse outcome in patients with heart failure and acute myocardial infarction (AMI). Nevertheless, data concerning the impact of anaemia and ID on clinical outcomes in patients with cardiogenic shock (CS) are scarce. This study aimed to assess the impact of anaemia and ID on clinical outcomes in patients with CS complicating AMI.
View Article and Find Full Text PDFClin Res Cardiol
April 2024
Department of Cardiology, University Heart and Vascular Center Hamburg, Martinistr. 52, 20251, Hamburg, Germany.
Heliyon
November 2023
German Heart Center Berlin, Department of Electrophysiology, Berlin, Germany.
Background: Subpopulations of myocardial c-kit cells have the ability to stimulate regeneration in ischemic heart disease by paracrine effects. The left atrial appendage (LAA), which is easy accessible during cardiac surgery, may represent a perfect source for c-kit cell extraction for autologous cell therapies in the living human. So far, frequency and distribution of c-kit cells in LAA are unknown.
View Article and Find Full Text PDFHeart Fail Clin
January 2024
Division of Cardiology, Department of Medicine, Duke University, Durham, NC, USA; Duke Clinical Research Institute, Durham, NC, USA. Electronic address:
Elevated left atrial pressure during exercise is a hallmark of heart failure (HF) and is associated with adverse left atrial remodeling and poor outcomes. To decompress the pressure-overloaded left atrium in patients with HF, several device-based approaches have been developed to create a permanent, pressure-dependent, left-to-right interatrial shunt. Such approaches are currently in various stages of investigations in both HF with reduced ejection fraction (EF) and HF with preserved EF.
View Article and Find Full Text PDFJACC Cardiovasc Interv
October 2023
Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address:
EBioMedicine
October 2023
Department of Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany; Leipzig Heart Institute at Heart Center Leipzig, Leipzig, Germany. Electronic address:
Background: Whether there is a subset of patients with heart failure with preserved ejection fraction (HFpEF) that benefit from spironolactone therapy is unclear. We applied a machine learning approach to identify responders and non-responders to spironolactone among patients with HFpEF in two large randomized clinical trials.
Methods: Using a reiterative cluster allocating permutation approach, patients from the derivation cohort (Aldo-DHF) were identified according to their treatment response to spironolactone with respect to improvement in E/e'.
Eur Radiol
March 2024
Department of Diagnostic and Interventional Radiology, Heart Center Leipzig, Strümpellstr. 39, 04289, Leipzig, Germany.
Objective: To investigate the feasibility and image quality of high-pitch CT pulmonary angiography (CTPA) with reduced iodine volume in normal weight patients.
Methods: In total, 81 normal weight patients undergoing CTPA for suspected pulmonary arterial embolism were retrospectively included: 41 in high-pitch mode with 20 mL of contrast medium (CM); and 40 with normal pitch and 50 mL of CM. Subjective image quality was assessed and rated on a 3-point scale.